Hot-selling Mepivacaine Hcl - Ropivacaine HCL CAS132112-35-7 – Kaimubuke
Hot-selling Mepivacaine Hcl - Ropivacaine HCL CAS132112-35-7 – Kaimubuke Detail:
What is Ropivacaine hydrochloride?
Ropika hydrochloride is a long-acting local anesthetic of the amide type. Its fat solubility is greater than lidocaine and less than bupivacaine, and its anesthesia strength is 8 times that of procaine. Because its Chemicalbook also has a local anesthetic effect in the liver metabolized products, the effect is longer. Mainly used for regional block anesthesia and epidural anesthesia, for postoperative and labor analgesia.
Detaied images
C A S: 132112-35-7
Appearance: white or off white powder
Chemical name: (S)-1-propyl-2′,6′-dimethyl-anilino-formoxy1piperidine, monohydrochloride, monohydrate
Molecular formula: C17H26N2O·HCl·H2O
Molecular weight: 328.88
Storage: Store in an airtight container , protected from light.
Melting point:122-126°C
Related impurities: ≤0.5%
Assay(HPLC): ≥98.0%
Product detail pictures:
Related Product Guide:
We can always satisfy our respected customers with our good quality, good price and good service due to we are more professional and more hard-working and do it in cost-effective way for Hot-selling Mepivacaine Hcl - Ropivacaine HCL CAS132112-35-7 – Kaimubuke , The product will supply to all over the world, such as: Malta, Greenland, South Korea, To achieve reciprocal advantages, our company is widely boosting our tactics of globalization in terms of communication with overseas customers, fast delivery, the best quality and long-term cooperation. Our company upholds the spirit of "innovation, harmony, team work and sharing, trails, pragmatic progress". Give us a chance and we will prove our capability. With your kind help, we believe that we can create a bright future with you together.
By Rita from Macedonia - 2018.06.21 17:11
The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
By Susan from Paris - 2017.02.18 15:54
